UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Clinical evidence of a graft-versus-lymphoma effect against relapsed diffuse large B-cell lymphoma after allogeneic hematopoietic stem-cell transplantation

Annals of oncology, 2008-11, Vol.19 (11), p.1935-1940

2008

Volltextzugriff (PDF)

Temsirolimus-resistant, checkpoint-deficient, homeostatic cytokine-responsive autologous TH1/TC1 cells for therapy of relapsed, refractory multiple myeloma (RRMM)

Cytotherapy (Oxford, England), 2021-05, Vol.23 (5), p.S86-S86

2021

Volltextzugriff (PDF)

Induced hybrid Treg/Th2 RAPA-501 cells for therapy of amyotrophic lateral sclerosis (ALS)

Cytotherapy (Oxford, England), 2021-05, Vol.23 (5), p.S101-S102

2021

Volltextzugriff (PDF)

In vivo biologic activity of induced hybrid TREG/Th2 RAPA-501 cells for als therapy: correction of TSCM:TEMimbalance, normalization of IL-6 secretion, and reduction in serum NF-L levels

Cytotherapy (Oxford, England), 2021-05, Vol.23 (5), p.S102-S102

2021

Volltextzugriff (PDF)

Clinical laboratory markers of inflammation as determinants of chronic graft-versus-host disease activity and NIH global severity

Leukemia, 2012-04, Vol.26 (4), p.633-643

2012

Volltextzugriff (PDF)

Determinants of functional performance in long-term survivors of allogeneic hematopoietic stem cell transplantation with chronic graft-versus-host disease (cGVHD)

Bone marrow transplantation (Basingstoke), 2010-04, Vol.45 (4), p.762-769

2010

Volltextzugriff (PDF)

NIH response criteria measures are associated with important parameters of disease severity in patients with chronic GVHD

Bone marrow transplantation (Basingstoke), 2014-12, Vol.49 (12), p.1513-1520

2014

Volltextzugriff (PDF)

Engineered human Tmpk fused with truncated cell-surface markers: versatile cell-fate control safety cassettes

Gene therapy, 2013-01, Vol.20 (1), p.24-34

2013

Volltextzugriff (PDF)

Neoantigen and tumor antigen-specific immunity transferred from immunized donors is detectable early after allogeneic transplantation in myeloma patients

Bone marrow transplantation (Basingstoke), 2013-02, Vol.48 (2), p.269-277

2013

Volltextzugriff (PDF)

STAT1 Deficiency Fails to Protect Against Murine Chronic GVHD

Biology of blood and marrow transplantation, 2011, Vol.17 (2), p.S332-S333

2011

Volltextzugriff (PDF)

Differential immune responses mediated by adenovirus- and lentivirus-transduced DCs in a HER-2 neu overexpressing tumor model

Gene therapy, 2011-10, Vol.18 (10), p.986-995

2011

Volltextzugriff (PDF)

STAT3 Promotes Both Natural and Inducible T Regulatory Cell Plasticity During Murine Acute GVHD

Biology of blood and marrow transplantation, 2011, Vol.17 (2), p.S288-S288

2011

Volltextzugriff (PDF)

Ultra-short course sirolimus contributes to effective GVHD prophylaxis after reduced-intensity allogeneic hematopoietic cell transplantation

Bone marrow transplantation (Basingstoke), 2012-12, Vol.47 (12), p.1552-1557

2012

Volltextzugriff (PDF)

Human T Cell Rapamycin Resistance And Th1/Tc1 Polarization Augment Xenogeneic Graft-Versus-Host Disease

Biology of blood and marrow transplantation, 2010, Vol.16 (2), p.S304-S304

2010

Volltextzugriff (PDF)

Retrovirally transduced murine T lymphocytes expressing FasL mediate effective killing of prostate cancer cells

Cancer gene therapy, 2009-05, Vol.16 (5), p.439-452

2009

Volltextzugriff (PDF)

Role of Clinical Laboratory Markers of inflammation in Assessing Chronic Graft Versus Host Disease (cGVHD) Activity and Severity

Biology of blood and marrow transplantation, 2011, Vol.17 (2), p.S340-S341

2011

Volltextzugriff (PDF)

284: Graft Rejection as a Type I Immune Response Amenable to Modulation by Type II Donor T Cells via an “Infectious” Mechanism

Biology of blood and marrow transplantation, 2008, Vol.14 (2), p.105-105

2008

Volltextzugriff (PDF)

T-Rapa Cell DLI Safely Balances Th1/Th2 Cytokine Activation After Low-Intensity Allogeneic Hematopoietic Cell Transplantation

Biology of blood and marrow transplantation, 2011, Vol.17 (2), p.S157-S157

2011

Volltextzugriff (PDF)

Validation of the National Institutes of Health (NIH) Consensus Criteria for Chronic GVHD (cGVHD) Staging Correlated With Established Indicators of Disease Severity and Prognosis

Biology of blood and marrow transplantation, 2011, Vol.17 (2), p.S160-S161

2011

Volltextzugriff (PDF)

234: Rapamycin generated donor Th2/Tc2 cells prevent graft rejection by inhibition of alloreactivity and not by deletion of alloreactive T cells

Biology of blood and marrow transplantation, 2007, Vol.13 (2), p.86-86

2007

Volltextzugriff (PDF)

336: Relative Contribution of CD127 Negative Selection, Rapamycin, and TGF-β to the Generation of Human Regulatory T Cells that Inhibit Alloreactivity via Dendritic Cell Modulation

Biology of blood and marrow transplantation, 2008, Vol.14 (2), p.123-124

2008

Volltextzugriff (PDF)

Prospective Evaluation of Immune Hemolysis in Minor-ABO Incompatible Reduced-Intensity Peripheral Blood (PB) Hematopoietic Cell Transplantation (HCT)

Blood, 2005-11, Vol.106 (11), p.960-960

2005

Volltextzugriff (PDF)

Yet more on Meno 82a-85d

Phronesis (Leiden, Netherlands), 1990, Vol.35 (1-3), p.175-181

Fowler, D.H

1990

Volltextzugriff (PDF)

1CD3, CD28 co-stimulated syngeneic T cells mediate GVL against murine myeloma: TH1/TC1 > TH2/TC2

Biology of blood and marrow transplantation, 2003-02, Vol.9 (2), p.61-61

2003

Volltextzugriff (PDF)

CD8+ T Cells of Tc2 Phenotype Mediate a GVL Effect and Prevent Marrow Rejection

Vox sanguinis, 1998-06, Vol.74 (S2), p.331-340

1998

Volltextzugriff (PDF)

1 – 25 von 81

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(47)
Mit Volltextzugriff
(69)

Publikationsform

Artikel
(67)
Tagungsberichte
(14)

Sprache

Englisch
(81)
Japanisch
(4)

Erscheinungsjahr

n.n

Thema

Science & Technology
(32)
Life Sciences & Biomedicine
(22)
Humans
(16)
Biological And Medical Sciences
(12)
Medical Sciences
(11)
Animals
(10)
Explosives
(10)
Male
(10)
Hematology, Oncology And Palliative Medicine
(9)
Laboratories
(9)
Switches
(9)
Technology
(9)
Adult
(8)
Female
(8)
Middle Aged
(8)
Physical Sciences
(8)
Physics
(8)
Hematology
(7)
Oncology
(7)
Aged
(6)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Clinical evidence of a graft-versus-lymphoma effect against relapsed diffuse large B-cell lymphoma after allogeneic hematopoietic stem-cell transplantation

Temsirolimus-resistant, checkpoint-deficient, homeostatic cytokine-responsive autologous TH1/TC1 cells for therapy of relapsed, refractory multiple myeloma (RRMM)

Induced hybrid Treg/Th2 RAPA-501 cells for therapy of amyotrophic lateral sclerosis (ALS)

In vivo biologic activity of induced hybrid TREG/Th2 RAPA-501 cells for als therapy: correction of TSCM:TEMimbalance, normalization of IL-6 secretion, and reduction in serum NF-L levels

Clinical laboratory markers of inflammation as determinants of chronic graft-versus-host disease activity and NIH global severity

Determinants of functional performance in long-term survivors of allogeneic hematopoietic stem cell transplantation with chronic graft-versus-host disease (cGVHD)

NIH response criteria measures are associated with important parameters of disease severity in patients with chronic GVHD

Engineered human Tmpk fused with truncated cell-surface markers: versatile cell-fate control safety cassettes

Neoantigen and tumor antigen-specific immunity transferred from immunized donors is detectable early after allogeneic transplantation in myeloma patients

STAT1 Deficiency Fails to Protect Against Murine Chronic GVHD

Differential immune responses mediated by adenovirus- and lentivirus-transduced DCs in a HER-2 neu overexpressing tumor model

STAT3 Promotes Both Natural and Inducible T Regulatory Cell Plasticity During Murine Acute GVHD

Ultra-short course sirolimus contributes to effective GVHD prophylaxis after reduced-intensity allogeneic hematopoietic cell transplantation

Human T Cell Rapamycin Resistance And Th1/Tc1 Polarization Augment Xenogeneic Graft-Versus-Host Disease

Retrovirally transduced murine T lymphocytes expressing FasL mediate effective killing of prostate cancer cells

Role of Clinical Laboratory Markers of inflammation in Assessing Chronic Graft Versus Host Disease (cGVHD) Activity and Severity

284: Graft Rejection as a Type I Immune Response Amenable to Modulation by Type II Donor T Cells via an “Infectious” Mechanism

T-Rapa Cell DLI Safely Balances Th1/Th2 Cytokine Activation After Low-Intensity Allogeneic Hematopoietic Cell Transplantation

Validation of the National Institutes of Health (NIH) Consensus Criteria for Chronic GVHD (cGVHD) Staging Correlated With Established Indicators of Disease Severity and Prognosis

234: Rapamycin generated donor Th2/Tc2 cells prevent graft rejection by inhibition of alloreactivity and not by deletion of alloreactive T cells

336: Relative Contribution of CD127 Negative Selection, Rapamycin, and TGF-β to the Generation of Human Regulatory T Cells that Inhibit Alloreactivity via Dendritic Cell Modulation

Prospective Evaluation of Immune Hemolysis in Minor-ABO Incompatible Reduced-Intensity Peripheral Blood (PB) Hematopoietic Cell Transplantation (HCT)

Yet more on Meno 82a-85d

1CD3, CD28 co-stimulated syngeneic T cells mediate GVL against murine myeloma: TH1/TC1 > TH2/TC2

CD8+ T Cells of Tc2 Phenotype Mediate a GVL Effect and Prevent Marrow Rejection

Suchergebnisse filtern